TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 107 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,445 | +31.5% | 1,657 | +33.7% | 0.00% | +100.0% |
| Q2 2023 | $22,389 | +43.8% | 1,239 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $15,574 | -14.3% | 1,239 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $18,164 | -14.4% | 1,239 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $21,212 | +17.3% | 1,239 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $18,089 | -80.7% | 1,239 | -45.4% | 0.00% | 0.0% |
| Q4 2020 | $93,860 | – | 2,271 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
| Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
| Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
| Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
| RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
| COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
| Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
| Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
| TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
| Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |